Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
SANUWAVE HealthSNWV -1.75%29 Earnings Yield (Joel Greenblatt) % is 18.48% as of Jun. 2026. GuruFocus rates SNWV with a GF Score™ of 29/100 and a GF Value™ of $12.84 (Possible Value Trap). The stock has 7 warning signs investors should review. Among 849 Medical Devices & Instruments companies, SANUWAVE Health ranks better than 98.59% on this metric.
SANUWAVE Health's Enterprise Value for the quarter that ended in Jun. 2026 was $97.35 Mil.
SANUWAVE Health's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 was $17.99 Mil. SANUWAVE Health's Earnings Yield (Joel Greenblatt) for the quarter that ended in Jun. 2026 was 18.48%.
The historical rank and industry rank for SANUWAVE Health's Earnings Yield (Joel Greenblatt) % or its related term are showing as below:
SNWV'
s Earnings Yield (Joel Greenblatt) % Range Over the Past 10 Years
Min: -72.3 Med: -13.27 Max: 34.53
Current: 32.79
During the past 13 years, the highest Earnings Yield (Joel Greenblatt) of SANUWAVE Health was 34.53%. The lowest was -72.30%. And the median was -13.27%.
SNWV's Earnings Yield (Joel Greenblatt) % is ranked better than 98.59% of 849
companies
in the Medical Devices & Instruments industry
Industry Median: 0.86
vs SNWV: 32.79
Joel Greenblatt's definition of earnings yield has the same problems the regular earnings yield does. It does not consider the growth of the company. It only looks at one-year's business operation. For cyclical companies, the earnings yield is usually highest at the peak of the business cycle. But these earnings are rarely sustainable.
A better indicator of the attractiveness of an investment which takes growth into account is the Forward Rate of Return (Yacktman) %. SANUWAVE Health's Forward Rate of Return (Yacktman) % for the quarter that ended in Jun. 2026 was 0.00%. The Forward Rate of Return uses the normalized Free Cash Flow of the past five years, and considers growth. The forward rate of return can be thought of as the return that investors buying the stock today can expect from it in the future.
SANUWAVE Health (NAS:SNWV) Earnings Yield (Joel Greenblatt) % Explanation
Joel Greenblatt defines the earnings yield using the above equation because it more accurately reflects the company's profitability relative to its stock price. Items like interest payment and tax etc. are not directly related to the company's operational profitability.
Enterprise Value instead of market cap (share price) is used in the calculation because it is the real price stock and bond investors together pay for the company.
Be Aware
Joel Greenblatt's definition of earnings yield has the same problems the regular earnings yield does. It does not consider the growth of the company. It only looks at one-year's business operation. For cyclical companies, the earnings yield is usually highest at the peak of the business cycle. But these earnings are rarely sustainable.
SANUWAVE Health Earnings Yield (Joel Greenblatt) % Related Terms
SANUWAVE Health Earnings Yield (Joel Greenblatt) % Historical Data
* Premium members only.
The historical data trend for SANUWAVE Health's Earnings Yield (Joel Greenblatt) % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SANUWAVE Health Earnings Yield (Joel Greenblatt) % Chart
For the Medical Devices subindustry, SANUWAVE Health's Earnings Yield (Joel Greenblatt) %, along with its competitors' market caps and Earnings Yield (Joel Greenblatt) % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
SANUWAVE Health Earnings Yield (Joel Greenblatt) % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, SANUWAVE Health's Earnings Yield (Joel Greenblatt) % distribution charts can be found below:
* The bar in red indicates where SANUWAVE Health's Earnings Yield (Joel Greenblatt) % falls into.
SANUWAVE Health Earnings Yield (Joel Greenblatt) % Calculation
In his book, The Little That Beat the Market, hedge fund manager Joel Greenblatt defines Earnings Yield as operating income divided by enterprise value.
SANUWAVE Healths Earnings Yield (Joel Greenblatt) for the fiscal year that ended in Dec. 2025 is calculated as
SANUWAVE Health's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $17.99 Mil.
What does a Earnings Yield (Joel Greenblatt) % of 18.48% mean?
SANUWAVE Health (SNWV) has a Earnings Yield (Joel Greenblatt) % of 18.48% as of Jun. 2026. Joel Greenblatt's earnings yield equals the ratio of earnings before interest and taxes to enterprise value. View historical data on SANUWAVE Health and its competitors. According to the industry distribution chart, SANUWAVE Health ranks #12 out of 849 companies in the Medical Devices & Instruments industry, placing it in the top 1.4%.
Is SANUWAVE Health's Earnings Yield (Joel Greenblatt) % too high?
SANUWAVE Health's current Earnings Yield (Joel Greenblatt) % is 18.48%. The Medical Devices & Instruments industry median Earnings Yield (Joel Greenblatt) % is 0.86. SANUWAVE Health's value of 18.48% is 2048.8% above this industry median. Based on the distribution chart, SANUWAVE Health ranks #12 out of 849 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, SANUWAVE Health has a GF Score™ of 29/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does SANUWAVE Health's Earnings Yield (Joel Greenblatt) % compare to SRTS and COCH?
According to the Medical Devices & Instruments industry distribution chart, SANUWAVE Health ranks #12 out of 849 companies for Earnings Yield (Joel Greenblatt) %. This places SANUWAVE Health in the top 1% of its industry — outperforming the majority of peers. The industry median Earnings Yield (Joel Greenblatt) % is 0.86. SANUWAVE Health's value of 18.48% is 2048.8% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Earnings Yield (Joel Greenblatt) % for a Medical Devices & Instruments company?
The median Earnings Yield (Joel Greenblatt) % among Medical Devices & Instruments companies is 0.86, based on 849 companies in the industry. Companies in the top quartile (top 25%) have a Earnings Yield (Joel Greenblatt) % significantly above this median, while those in the bottom quartile fall well below. However, Earnings Yield (Joel Greenblatt) % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. SANUWAVE Health's current Earnings Yield (Joel Greenblatt) % of 18.48% is 2048.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Earnings Yield (Joel Greenblatt) % mean?
A high Earnings Yield (Joel Greenblatt) % can signal that a stock is expensive relative to its fundamentals. Joel Greenblatt's earnings yield equals the ratio of earnings before interest and taxes to enterprise value. View historical data on SANUWAVE Health and its competitors. For the Medical Devices & Instruments industry, the median Earnings Yield (Joel Greenblatt) % is 0.86 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. SANUWAVE Health's current Earnings Yield (Joel Greenblatt) % is 18.48%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SANUWAVE Health stock overvalued right now?
Based on GuruFocus' analysis, SANUWAVE Health (SNWV) is currently considered Possible Value Trap. The stock's GF Value™ is $12.84, compared to a current price of $5.06 — trading 60.6% below its estimated fair value. The current Earnings Yield (Joel Greenblatt) % is 18.48% and 2048.8% above the Medical Devices & Instruments industry median of 0.86. SANUWAVE Health's overall GF Score™ is 29/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Earnings Yield (Joel Greenblatt) % calculated?
Earnings Yield (Joel Greenblatt) % is calculated from a company's financial statements. For SANUWAVE Health (SNWV), the current Earnings Yield (Joel Greenblatt) % is 18.48% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is SANUWAVE Health (SNWV) Overvalued in 2026?
Based on GuruFocus' analysis, SANUWAVE Health stock appears to be undervalued.
The current stock price of $5.06 is trading 60.6% below its estimated GF Value™ of $12.84.
GuruFocus considers SANUWAVE Health to be Possible Value Trap.
Key valuation signals for SNWV:
Earnings Yield (Joel Greenblatt) %: 18.48%
GF Value™: $12.84 vs. price of $5.06 (60.6% below fair value)
Industry Position: 2048.8% above the Medical Devices & Instruments median (#12 of 849)
No single metric tells the full story. See the SNWV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
SANUWAVE Health Inc is a medical device company providing directed energy products into the wound care space. It is focused on the commercialization of its patented regenerative medicine utilizing noninvasive ultrasound or shockwaves to produce a biological response promoting the repair and regeneration of tissue, musculoskeletal, and vascular structures. Sanuwave's patented, FDA-cleared, and commercialised product is the UltraMIST system, which is used to treat a variety of acute and chronic wounds using ultrasound technology. The company operates in one reportable segment, the design and sale of medical devices. Geographically, the company generates revenue mainly from the United States.
29GF Score
Get the complete analysis for SNWV
Earnings Yield (Joel Greenblatt) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SNWV has been successfully added to your 
